Displaying 680 results out of a total of 3930 publications.
Target-Based Discovery of an Inhibitor of the Regulatory Phosphatase PPP1R15B
Krzyzosiak, A;Sigurdardottir, A;Luh, L;Carrara, M;Das, I;Schneider, K;Bertolotti, A;
Cell, Cell ():, 2018
View publication
Cell, Cell ():, 2018
Abnormal morphological and functional nature of bone marrow stromal cells provides preferential support for survival of acute myeloid leukemia cells
Yehudai-Resheff, S;Attias-Turgeman, S;Sabbah, R;Gabay, T;Musallam, R;Fridman-Dror, A;Zuckerman, T;
Int. J. Cancer, Int. J. Cancer ():, 2018
View publication
Int. J. Cancer, Int. J. Cancer ():, 2018
phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer
Wang, C;Jin, H;Gao, D;Lieftink, C;Evers, B;Jin, G;Xue, Z;Wang, L;Beijersbergen, RL;Qin, W;Bernards, R;
J. Hepatol., J. Hepatol. ():, 2018
View publication
J. Hepatol., J. Hepatol. ():, 2018
Combining Tumor Microenvironment Modulating Nanoparticles with Doxorubicin to Enhance Chemotherapeutic Efficacy and Boost Antitumor Immunity
Amini, MA;Abbasi, AZ;Cai, P;Lip, H;Gordijo, CR;Li, J;Chen, B;Zhang, L;Rauth, AM;Wu, XY;
J. Natl. Cancer Inst., J. Natl. Cancer Inst. ():, 2018
View publication
J. Natl. Cancer Inst., J. Natl. Cancer Inst. ():, 2018
The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse model
Ghazaryan, N;Movsisyan, N;Macedo, JC;Vaz, S;Ayvazyan, N;Pardo, L;Logarinho, E;
Invest New Drugs, Invest New Drugs ():, 2019
View publication
Invest New Drugs, Invest New Drugs ():, 2019
Type II RAF inhibitor causes superior ERK pathway suppression compared to type I RAF inhibitor in cells expressing different BRAF mutant types recurrently found in lung cancer
Noeparast, A;Giron, P;De Brakeleer, S;Eggermont, C;De Ridder, U;Teugels, E;De Grve, J;
Oncotarget, Oncotarget 9(22):16110-16123, 2018
View publication
Oncotarget, Oncotarget 9(22):16110-16123, 2018
Insights into the Action of Inhibitor Enantiomers against Histone Lysine Demethylase 5A
Horton, JR;Liu, X;Wu, L;Zhang, K;Shanks, J;Zhang, X;Rai, G;Mott, BT;Jansen, DJ;Kales, SC;Henderson, MJ;Pohida, K;Fang, Y;Hu, X;Jadhav, A;Maloney, DJ;Hall, MD;Simeonov, A;Fu, H;Vertino, PM;Yan, Q;Cheng, X;
J. Med. Chem., J. Med. Chem. ():, 2018
View publication
J. Med. Chem., J. Med. Chem. ():, 2018
PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth
Morita, M;Sato, T;Nomura, M;Sakamoto, Y;Inoue, Y;Tanaka, R;Ito, S;Kurosawa, K;Yamaguchi, K;Sugiura, Y;Takizaki, H;Yamashita, Y;Katakura, R;Sato, I;Kawai, M;Okada, Y;Watanabe, H;Kondoh, G;Matsumoto, S;Kishimoto, A;Obata, M;Matsumoto, M;Fukuhara, T;Motohashi, H;Suematsu, M;Komatsu, M;Nakayama, KI;Watanabe, T;Soga, T;Shima, H;Maemondo, M;Tanuma, N;
Cancer Cell, Cancer Cell 33(3):355-367.e7, 2018
View publication
Cancer Cell, Cancer Cell 33(3):355-367.e7, 2018
Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma
Sredni, ST;Bailey, AW;Suri, A;Hashizume, R;He, X;Louis, N;Gokirmak, T;Piper, DR;Watterson, DM;Tomita, T;
Oncotarget, Oncotarget 8(67):111190-111212, 2017
View publication
Oncotarget, Oncotarget 8(67):111190-111212, 2017
Itraconazole targets cell cycle heterogeneity in colorectal cancer
Buczacki, SJA;Popova, S;Biggs, E;Koukorava, C;Buzzelli, J;Vermeulen, L;Hazelwood, L;Francies, H;Garnett, MJ;Winton, DJ;
J. Exp. Med., J. Exp. Med. 215(7):1891-1912, 2018
View publication
J. Exp. Med., J. Exp. Med. 215(7):1891-1912, 2018